Obermatt

KORU Medical Systems

NAQ:KRMD · US7599101026
Health Care Equipment & SuppliesSmall

360

40
Profit price95
Owner Earnings Yield1
Dividend Yield1
Price/Sales54
EV / Gross Profit28
Price/Book10
Return on Capital49
Cash Return on Capital49
Return on Equity57
EBIT Margin55
Gross Profitability96
Accruals66
Owner Earnings Margin52
Sales growth55
Profit growth63
Reinvestment16
Price momentum53
Debt load64
Refinancing71
Debt Payback1
Liquidity17
Analyst ratings60
Opinion Changes50
Price Target Upside64
Market mood100
Value Creation10/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

KORU Medical Systems clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
TypePublic Company
ExchangeNASDAQCM
Founded1980
Employees74
ISINUS7599101026
Last UpdateApr 2, 2026
Themes
ImmunologyChronic DiseasesHematologyBiomedical EngineeringHealth CareManufacturingMedical Device

Description

KORU Medical Systems, Inc. (KORU) develops, manufactures, and commercializes innovative, patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market, as governed by the United States Food and Drug…

Analysis

Middle-of-the-road

KORU Medical Systems, Inc. sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

Valuation data is not available for this company.

Growth is moderate; the safety picture is stretched. The company scores 10/20 on our value-creation score: creating some value.

Flags to be aware of: Some accounting patterns deserve a closer look. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
36
2023202420252026

All-time high

81

Jan 2024

All-time low

19

Jan 2023

Average rank

53

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
54
31
51
45
Price/Earnings
1
52
52
52
Price/Book
10
18
48
48
Dividend Yield
1
1
1
1
Value (overall)
1
25
40
43

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare KORU Medical Systems with its peers
Senstar Technologies
NMQ:SNT
56
CountryCanada
IndustryElectronic Equipment, Instruments & Components
SizeSmall
Full Stock Analysis →
Pulse Biosciences
NAQ:PLSE
45
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Rigel Pharmaceuticals
NSQ:RIGL
66
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
MannKind
NMQ:MNKD
24
CountryUSA
IndustryBiotechnology
SizeMedium
Full Stock Analysis →
Cardiol Therapeutics
TOR:CRDL
81
CountryCanada
IndustryPharmaceuticals
SizeX-Small
Full Stock Analysis →
Xeris Pharmaceuticals
NSQ:XERS
70
CountryUSA
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →